Development

A GLP-1 drug slows biological aging in a controlled trial

development2026-06-08

Claim

A UC San Diego team reported semaglutide slows biological aging in adults with HIV, cutting the pace 9% on the DunedinPACE clock in the first randomized, placebo-controlled sign that a GLP-1 drug touches aging itself.

Reported metric: -9% pace of aging

Reporting date: 2026-06-08 (not necessarily the event date)

Sources

Attribution and reporting linked by this record; links do not imply independent verification.

Welcome to June 8, 2026 (theinnermostloop.substack.com)

Knowledge graphopen in browser →

Reported in

Welcome to June 8, 2026

Actor

UC San Diego

Evidence for

Supersedes

Leaving the workforce early may accelerate cognitive decline

Referenced by

Cite or correct this record

Citation formatCitation text

A GLP-1 drug slows biological aging in a controlled trial
Innermost Loop KB — secondary record
Reporting date: 2026-06-08
KB permalink: https://nicholsn.github.io/innermost-loop-kb/developments/2026-06-08-a-glp-1-drug-slows-biological-aging
Claim: A UC San Diego team reported semaglutide slows biological aging in adults with HIV, cutting the pace 9% on the DunedinPACE clock in the first randomized, placebo-controlled sign that a GLP-1 drug touches aging itself.
Attributed sources:
- Welcome to June 8, 2026 — https://theinnermostloop.substack.com/p/welcome-to-june-8-2026
This citation does not imply independent verification of linked-source claims.

Suggest a correction — opens a GitHub draft for you to review and submit.